Palbociclib Impurity 95 - Request Quote
Palbociclib Impurity 95
| SZ CAT No: | SZ-P015128 |
| CAS No | NA |
| Mol.F. | C28H35N7O6 |
| Mol.Wt. | 565.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Palbociclib Impurity 95 is chemically 4-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)oxy)-4-oxobutanoic acid. Palbociclib Impurity 95 is supplied with detailed characterization data compliant with regulatory guideline. Palbociclib Impurity 95 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Palbociclib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Palbociclib Impurity 95
Purchase Palbociclib Impurity 95
Palbociclib Impurity 95 suppliers
Palbociclib Impurity 95 manufacturers
Palbociclib Impurity 95 price
Order Palbociclib Impurity 95
Enquire Palbociclib Impurity 95
Palbociclib Impurity 95 cost
Palbociclib Impurity 95 Supplier
Palbociclib Impurity 95 Distributor
Palbociclib Impurity 95 for Method Validation
Palbociclib Reference Standard
Palbociclib Impurity 95 for ANDA Filing
Palbociclib Impurity 95 for Forced Degradation Studies
Palbociclib Impurity 95 Identification Standards
Palbociclib Impurity 95 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.